Boston Scientific Warns of 2026 Sales and Profit Shortfalls After Cyberattack

POLICY WIRE — Boston, United States — Boston Scientific has announced that a recent cyberattack is expected to significantly impact its financial performance for the third quarter and full year of...

Editorial Desk

September 8, 2026 One Min Read

POLICY WIRE — Boston, United States — Boston Scientific has announced that a recent cyberattack is expected to significantly impact its financial performance for the third quarter and full year of 2026.

The medical device company revealed in a regulatory filing with the Securities and Exchange Commission that it is unlikely to meet its previously issued net sales growth and adjusted earnings per share (EPS) guidance for both the third quarter and the full year.

Despite efforts to restore operations globally, the firm acknowledged that the full financial consequences of the incident remain uncertain. Boston Scientific plans to provide updated outlooks during its upcoming earnings call on October 28, though it does not anticipate long-term damage to its financial position.

📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES

👉 READ BY CLICKING HERE

Reporting by Policy-Wire (PW)

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.